VEGFR2/KDR/Flk-1 Antibody (Avas12a1) - BSA Free

Flow Cytometry: VEGF R2/KDR/Flk-1 Antibody (Avas12a1) [NBP1-43300] - Analysis using the Biotin conjugate of NBP1-43300. Staining of bEnd.3 cell line with Anti-Mouse CD309 (FLK1) PE. Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.

Flow Cytometry: VEGF R2/KDR/Flk-1 Antibody (Avas12a1) [NBP1-43300] - Staining of bEnd.3 cell line with Anti-Mouse CD309 (FLK1) PE. Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.

Product Discontinued

VEGFR2/KDR/Flk-1 Antibody (Avas12a1) - BSA Free Summary

• Immunogen: The immunogen for this antibody was Flk1.
• Marker: Endothelial Cell Marker
• Isotype: IgG2a Kappa
• Clonality: Monoclonal
• Host: Rat
• Gene: KDR
• Purity: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Flow Cytometry 1:10-1:1000
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Paraffin 1:10-1:500
  • Western Blot 1:100-1:2000

Packaging, Storage & Formulations

• Storage: Store at 4C. Do not freeze.
• Buffer: PBS (pH 7.2)
• Preservative: 0.09% Sodium Azide
• Concentration: 0.5 mg/ml
• Purity: Protein A or G purified

Alternate Names for VEGFR2/KDR/Flk-1 Antibody (Avas12a1) - BSA Free

• CD309 antigen
• CD309
• EC 2.7.10
• EC 2.7.10.1
• Fetal liver kinase 1
• fetal liver kinase-1
• Flk1
• Flk-1
• FLK1tyrosine kinase growth factor receptor
• KDR
• kinase insert domain receptor (a type III receptor tyrosine kinase)
• Kinase insert domain receptor
• KRD1
• Ly73
• Protein-tyrosine kinase receptor flk-1
• soluble VEGFR2
• vascular endothelial growth factor receptor 2
• VEGF R2
• VEGFR
• VEGFR2
• VEGFR-2

Background

The Avas12a1 monoclonal antibody reacts with mouse Flk-1, also known as vascular endothelial growth factor receptor 2 (VEGFR2). Flk-1 is a receptor tyrosine kinase involved in vascular endothelial tissue development and is expressed on endothelial cells during embryonic stages and some endothelial tissues in the adult.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for VEGFR2/KDR/Flk-1 Antibody (NBP1-43300)(3)

Publications using NBP1-43300

• Ribieras AJ, Ortiz YY, Li Y et al. E-Selectin/AAV2/2 Gene Therapy Alters Angiogenesis and Inflammatory Gene Profiles in Mouse Gangrene Model Frontiers in cardiovascular medicine 2022-06-16 [PMID: 35783833]
• Wei ST, Huang YC, Hsieh ML et al. Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling Cell Death Dis 2020-05-04 [PMID: 32366833] (FLOW, Mouse)
• Chatterjee I, Baruah J, Lurie EE, Wary KK. Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development. Cardiovasc. Res. 2016-04-28 [PMID: 27125875]

Bioinformatics

• Gene Symbol: KDR